These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8433213)

  • 1. Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies.
    Bártek J; Bártková J; Lukás J; Stasková Z; Vojtĕsek B; Lane DP
    J Pathol; 1993 Jan; 169(1):27-34. PubMed ID: 8433213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in epitope accessibility of p53 monoclonal antibodies suggest at least three conformations or states of protein binding of p53 protein in human tumor cell lines.
    Danks MK; Whipple DO; McPake CR; Lu D; Harris LC
    Cell Death Differ; 1998 Aug; 5(8):678-86. PubMed ID: 10200523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry.
    Bonsing BA; Corver WE; Gorsira MC; van Vliet M; Oud PS; Cornelisse CJ; Fleuren GJ
    Cytometry; 1997 May; 28(1):11-24. PubMed ID: 9136751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods in pathology. p53 expression in formalin-fixed, paraffin-embedded archival specimens of intrahepatic cholangiocarcinoma: retrieval of p53 antigenicity by microwave oven heating of tissue sections.
    Terada T; Shimizu K; Izumi R; Nakanuma Y
    Mod Pathol; 1994 Feb; 7(2):249-52. PubMed ID: 8008749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.
    Bártek J; Bártková J; Vojtĕsek B; Stasková Z; Lukás J; Rejthar A; Kovarík J; Midgley CA; Gannon JV; Lane DP
    Oncogene; 1991 Sep; 6(9):1699-703. PubMed ID: 1923535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 protein immunostaining in routinely processed paraffin-embedded sections.
    Bruner JM; Connelly JH; Saya H
    Mod Pathol; 1993 Mar; 6(2):189-94. PubMed ID: 8483890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms.
    Baas IO; Mulder JW; Offerhaus GJ; Vogelstein B; Hamilton SR
    J Pathol; 1994 Jan; 172(1):5-12. PubMed ID: 7931827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope analysis of the human p53 tumour suppressor protein.
    Dolezalová H; Vojtĕsek B; Kovarík J
    Folia Biol (Praha); 1997; 43(1):49-51. PubMed ID: 9158951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of human p53 specific monoclonal antibodies and their use in immunohistochemical studies of tumor cells.
    Legros Y; Lacabanne V; d'Agay MF; Larsen CJ; Pla M; Soussi T
    Bull Cancer; 1993 Feb; 80(2):102-10. PubMed ID: 7513565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection.
    Lambkin HA; Mothersill CM; Kelehan P
    J Pathol; 1994 Jan; 172(1):13-8. PubMed ID: 7931822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of p53 protein overexpression in primary human osteosarcomas.
    Bodey B; Gröger AM; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1997; 17(1A):493-8. PubMed ID: 9066701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A series of 14 new monoclonal antibodies to keratins: characterization and value in diagnostic histopathology.
    Bártek J; Vojtĕsek B; Stasková Z; Bártková J; Kerekés Z; Rejthar A; Kovarík J
    J Pathol; 1991 Jul; 164(3):215-24. PubMed ID: 1716305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular detection of Bcl-2 and p53 proteins by flow cytometry: comparison of monoclonal antibodies and sample preparation protocols.
    Zamai L; Canonico B; Gritzapis A; Luchetti F; Felici C; Della Felice M; Margomenou L; Papamichail M; Gratama JW; Papa S
    J Biol Regul Homeost Agents; 2002; 16(4):289-302. PubMed ID: 12597645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of p53 in the skin in systemic sclerosis. Immunohistochemical study of 8 cases].
    Pignone A; Calzolari A; Cerinic MM; Scaletti C; Messerini L; Lombardi A; Generini S; Giannelli E; Carossino A; Baroni G
    Pathologica; 1994 Aug; 86(4):392-5. PubMed ID: 7708439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunohistochemical analysis of heat shock protein 70, p53, and estrogen receptor status in carcinoma of the uterine cervix.
    Park CS; Joo IS; Song SY; Kim DS; Bae DS; Lee JH
    Gynecol Oncol; 1999 Jul; 74(1):53-60. PubMed ID: 10385551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-observer variation of p53 immunohistochemistry--an assessment of a practical problem and comparison with other studies.
    Kay EW; Barry Walsh CJ; Whelan D; O'Grady A; Leader MB
    Br J Biomed Sci; 1996 Jun; 53(2):101-7. PubMed ID: 8757686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of anti-p53 antibodies in immunoblotting.
    Turpeinen M; Serpi R; Rahkolin M; Vähäkangas K
    Biochem Biophys Res Commun; 2002 May; 293(2):850-6. PubMed ID: 12054549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tissue fixation conditions and protease pretreatment on immunohistochemical performance of a large series of new anti-keratin monoclonal antibodies: value in oncopathology.
    Bártková J; Bártek J; Lukás Z; Vojtĕsek B; Stasková Z; Bursová H; Pavlovská R; Rejthar A; Kovarík J
    Neoplasma; 1991; 38(4):439-46. PubMed ID: 1717857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 status in breast carcinomas revealed by FASAY correlates well with p53 protein accumulation determined by immunohistochemistry.
    Smardová J; Vagunda V; Jandáková E; Vagundová M; Koukalová H; Kovarík J; Zaloudík J
    Neoplasma; 1999; 46(6):384-9. PubMed ID: 10732868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of c-erbB-2 and p53 oncoprotein co-overexpression in human breast cancer.
    Barbati A; Cosmi EV; Sidoni A; Collini P; Porpora MG; Ferri I; Lüthy M; Lauro V; Bucciarelli E
    Anticancer Res; 1997; 17(1A):401-5. PubMed ID: 9066684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.